# US 2021/0277409 A1 · Methods for selecting transformed plants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277409 A1
- Document ID: US20210277409A1
- Status: Published application
- Kind: A1
- Application number: 17/255,132
- Filed: 2019-06-25
- Published: 2021-09-09
- Earliest claimed: 2018-06-28
- Assignees: Pioneer Hi-Bred International, Inc.
- Applicants: Pioneer Hi-Bred International, Inc.
- Inventors: AJITH ANAND; HYEON-JE CHO; THEODORE M KLEIN
- Web page: https://patentgrep.com/patent/US20210277409A1

## CPC

- C12N 9/12: transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N 15/8209: {Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Spectinomycin resistant or streptomycin resistant transgenic plants and methods of making such plants are provided.

## Claims

### Claim 1

A plant transformed with a recombinant expression cassette comprising a marker gene cassette comprising a DNA sequence imparting spectinomycin resistance or streptomycin resistance in plants, wherein the DNA sequence comprises a nucleotide sequence selected from the group consisting of:
(a) at least one of SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 21 and SEQ ID NO: 23, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants;
(b) a nucleotide sequence that is at least 95% identical to at least one of SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 21 and SEQ ID NO: 23, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants;
(c) a nucleotide sequence that is at least 70% identical to at least one of SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 21 and SEQ ID NO: 23, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants;
(d) a nucleotide sequence encoding a polypeptide of at least one of SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 22, and SEQ ID NO: 24, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants;
(e) a nucleotide sequence encoding a polypeptide that is at least 95% identical to at least one of SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 22, and SEQ ID NO: 24, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants; and
(f) a nucleotide sequence encoding a polypeptide that is at least 70% identical to at least one of SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 22, and SEQ ID NO: 24, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants.

### Claim 2 (depends on 1)

The plant of claim 1, wherein the recombinant expression cassette further comprises a trait gene cassette comprising a heterologous nucleotide sequence of interest.

### Claim 3 (depends on 2)

The plant of claim 2, wherein the heterologous nucleotide sequence of interest comprises a trait gene encoding a gene product conferring nutritional enhancement, pest resistance, herbicide resistance, abiotic stress tolerance, increased yield, drought resistance, cold tolerance, pathogen resistance, insect resistance, nitrogen use efficiency (NUE), disease resistance, or an ability to alter a metabolic pathway.

### Claim 4 (depends on 2)

The plant of claim 2, wherein the recombinant expression cassette further comprises a morphogenic gene cassette comprising a morphogenic gene.

### Claim 5 (depends on 4)

The plant of claim 4, wherein the morphogenic gene comprises:
(i) a nucleotide sequence encoding a WUS/WOX homeobox polypeptide; or
(ii) a nucleotide sequence encoding a Babyboom (BBM) polypeptide or an Ovule Development Protein 2 (ODP2) polypeptide; or
(iii) a combination of (i) and (ii).

### Claim 6 (depends on 5)

The plant of claim 5, wherein the morphogenic gene comprises the nucleotide sequence encoding the WUS/WOX homeobox polypeptide.

### Claim 7 (depends on 6)

The plant of claim 6, wherein the nucleotide sequence encoding the WUS/WOX homeobox polypeptide is selected from WUS1, WUS2, WUS3, WOX2A, WOX4, WOX5, and WOX9.

### Claim 8 (depends on 5)

The plant of claim 5, wherein the morphogenic gene comprises a nucleotide sequence encoding the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide.

### Claim 9 (depends on 8)

The plant of claim 8, wherein the nucleotide sequence encoding the Babyboom (BBM) polypeptide is selected from BBM2, BMN2, and BMN3 or the Ovule Development Protein 2 (ODP2) polypeptide is ODP2.

### Claim 10 (depends on 5)

The plant of claim 5, wherein the morphogenic gene comprises a nucleotide sequence encoding the WUS/WOX homeobox polypeptide and the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide.

### Claim 11 (depends on 10)

The plant of claim 10, wherein the nucleotide sequence encoding the WUS/WOX homeobox polypeptide is selected from WUS1, WUS2, WUS3, WOX2A, WOX4, WOX5, and WOX9 and the Babyboom (BBM) polypeptide is selected from BBM2, BMN2, and BMN3 or the Ovule Development Protein 2 (ODP2) polypeptide is ODP2.

### Claim 12 (depends on 4)

The plant of claim 4, wherein the recombinant expression cassette further comprises a site-specific recombinase cassette comprising a nucleotide sequence encoding a site-specific recombinase selected from FLP, Cre, SSV1, lambda Int, phi C31 Int, HK022, R, Gin, Tn1721, CinH, ParA, Tn5053, Bxbl, TP907-1, or U153.

### Claim 13 (depends on 12)

The plant of claim 12, wherein the site-specific recombinase is operably linked to a constitutive promoter, an inducible promoter, or a developmentally regulated promoter.

### Claim 14 (depends on 13)

The plant of claim 13, wherein the constitutive promoter is selected from UBI, LLDAV, EVCV, DMMV, BSV(AY) PRO, CYMV PRO FL, UBIZM PRO, SI-UB3 PRO, SB-UBI PRO (ALT1), USB1ZM PRO, ZM-GOS2 PRO, ZM-H1B PRO (1.2 KB), IN2-2, NOS, the −135 version of 35S, or ZM-ADF PRO (ALT2);
the inducible promoter is selected from AXIG1, DR5, XVE, GLB1, OLE, LTP2, HSP17.7, HSP26, HSP18A, AT-HSP811, AT-HSP811L, GM-HSP173B or promoters activated by tetracycline, ethamethsulfuron or chlorsulfuron; and
the developmentally regulated promoter is selected from PLTP, PLTP1, PLTP2, PLTP3, SDR, LGL, LEA-14A, or LEA-D34.

### Claim 15 (depends on 4)

The plant of claim 4, wherein the morphogenic gene is operably linked to a constitutive promoter, an inducible promoter, or a developmentally regulated promoter.

### Claim 16 (depends on 15)

The plant cell of claim 15, wherein the constitutive promoter is selected from UBI, LLDAV, EVCV, DMMV, BSV(AY) PRO, CYMV PRO FL, UBIZM PRO, SI-UB3 PRO, SB-UBI PRO (ALT1), USB1ZM PRO, ZM-GOS2 PRO, ZM-H1B PRO (1.2 KB), IN2-2, NOS, the −135 version of 35S, or ZM-ADF PRO (ALT2);
the inducible promoter is selected from AXIG1, DR5, XVE, GLB1, OLE, LTP2, HSP17.7, HSP26, HSP18A, AT-HSP811, AT-HSP811L, GM-HSP173B or promoters activated by tetracycline, ethamethsulfuron or chlorsulfuron; and
the developmentally regulated promoter is selected from PLTP, PLTP1, PLTP2, PLTP3, SDR, LGL, LEA-14A, or LEA-D34.

### Claim 17 (depends on 1)

The plant of claim 1, wherein the plant is a monocot or a dicot.

### Claim 18 (depends on 2)

A seed from the plant of claim 2, wherein the seed comprises the trait gene cassette and not the marker gene cassette.

### Claim 19 (depends on 4)

A seed from the plant of claim 4, wherein the seed comprises the trait gene cassette and not the marker gene cassette or the morphogenic gene cassette.

### Claim 20 (depends on 12)

A seed from the plant of claim 12, wherein the seed comprises the trait gene cassette and not the marker gene cassette or the morphogenic gene cassette or the site-specific recombinase cassette.

### Claim 21

A method of producing a transgenic plant expressing a trait gene cassette comprising:
transforming a plant cell with a recombinant expression cassette comprising a trait gene cassette and a marker gene cassette, the marker gene cassette comprising a DNA sequence imparting spectinomycin resistance or streptomycin resistance in plants, wherein the DNA sequence comprises a nucleotide sequence selected from the group consisting of:
(a) at least one of SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 21 and SEQ ID NO: 23, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants;
(b) a nucleotide sequence that is at least 95% identical to at least one of SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 21 and SEQ ID NO: 23, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants;
(c) a nucleotide sequence that is at least 70% identical to at least one of SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 21 and SEQ ID NO: 23, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants;
(d) a nucleotide sequence encoding a polypeptide of at least one of SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 22, and SEQ ID NO: 24, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants;
(e) a nucleotide sequence encoding a polypeptide that is at least 95% identical to at least one of SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 22, and SEQ ID NO: 24, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants; and
(f) a nucleotide sequence encoding a polypeptide that is at least 70% identical to at least one of SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 22, and SEQ ID NO: 24, wherein the nucleotide sequence imparts spectinomycin resistance or streptomycin resistance in plants;
selecting a spectinomycin resistant or a streptomycin resistant transgenic plant cell; and
regenerating the transgenic plant expressing the trait gene cassette.

### Claim 22 (depends on 21)

The method of claim 21, wherein the trait gene cassette comprises a heterologous nucleotide sequence of interest.

### Claim 23 (depends on 22)

The method of claim 22, wherein the heterologous nucleotide sequence of interest comprises a trait gene encoding a gene product conferring nutritional enhancement, pest resistance, herbicide resistance, abiotic stress tolerance, increased yield, drought resistance, cold tolerance, pathogen resistance, insect resistance, nitrogen use efficiency (NUE), disease resistance, or an ability to alter a metabolic pathway.

### Claim 24 (depends on 21)

The method of claim 21, wherein the recombinant expression cassette further comprises a morphogenic gene cassette.

### Claim 25 (depends on 24)

The method of claim 24, wherein the morphogenic gene cassette comprises a morphogenic gene.

### Claim 26 (depends on 25)

The method of claim 25, wherein the morphogenic gene comprises:
(i) a nucleotide sequence encoding a WUS/WOX homeobox polypeptide; or
(ii) a nucleotide sequence encoding a Babyboom (BBM) polypeptide or an Ovule Development Protein 2 (ODP2) polypeptide; or
(iii) a combination of (i) and (ii).

### Claim 27 (depends on 26)

The method of claim 26, wherein the morphogenic gene comprises a nucleotide sequence encoding the WUS/WOX homeobox polypeptide.

### Claim 28 (depends on 27)

The method of claim 27, wherein the nucleotide sequence encoding the WUS/WOX homeobox polypeptide is selected from WUS1, WUS2, WUS3, WOX2A, WOX4, WOX5, and WOX9.

### Claim 29 (depends on 26)

The method of claim 26, wherein the morphogenic gene comprises a nucleotide sequence encoding the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide.

### Claim 30 (depends on 29)

The method of claim 29, wherein the nucleotide sequence encoding the Babyboom (BBM) polypeptide is selected from BBM2, BMN2, and BMN3 or the Ovule Development Protein 2 (ODP2) polypeptide is ODP2.

### Claim 31 (depends on 26)

The method of claim 26, wherein the morphogenic gene comprises a nucleotide sequence encoding the WUS/WOX homeobox polypeptide and the Babyboom (BBM) polypeptide or the Ovule Development Protein 2 (ODP2) polypeptide.

### Claim 32 (depends on 31)

The method of claim 31, wherein the nucleotide sequence encoding the WUS/WOX homeobox polypeptide is selected from WUS1, WUS2, WUS3, WOX2A, WOX4, WOX5, and WOX9 and the Babyboom (BBM) polypeptide is selected from BBM2, BMN2, and BMN3 or the Ovule Development Protein 2 (ODP2) polypeptide is ODP2.

### Claim 33 (depends on 24)

The method of claim 24, wherein the recombinant expression cassette further comprises a site-specific recombinase cassette.

### Claim 34 (depends on 33)

The method of claim 33, wherein the site-specific recombinase cassette comprises a nucleotide sequence encoding a site-specific recombinase selected from FLP, Cre, SSV1, lambda Int, phi C31 Int, HK022, R, Gin, Tn1721, CinH, ParA, Tn5053, Bxb1, TP907-1, or U153.

### Claim 35 (depends on 34)

The method of claim 34, wherein the nucleotide sequence encoding the site-specific recombinase is operably linked to a constitutive promoter, an inducible promoter, or a developmentally regulated promoter.

### Claim 36 (depends on 35)

The method of claim 35, wherein the constitutive promoter is selected from UBI, LLDAV, EVCV, DMMV, BSV(AY) PRO, CYMV PRO FL, UBIZM PRO, SI-UB3 PRO, SB-UBI PRO (ALT1), USB1ZM PRO, ZM-GOS2 PRO, ZM-H1B PRO (1.2 KB), IN2-2, NOS, the −135 version of 35S, or ZM-ADF PRO (ALT2);
the inducible promoter is selected from AXIG1, DR5, XVE, GLB1, OLE, LTP2, HSP17.7, HSP26, HSP18A, AT-HSP811, AT-HSP811L, GM-HSP173B or promoters activated by tetracycline, ethamethsulfuron or chlorsulfuron; and
the developmentally regulated promoter is selected from PLTP, PLTP1, PLTP2, PLTP3, SDR, LGL, LEA-14A, or LEA-D34.

### Claim 37 (depends on 25)

The method of claim 25, wherein the morphogenic gene is operably linked to a constitutive promoter, an inducible promoter, or a developmentally regulated promoter.

### Claim 38 (depends on 37)

The method of claim 37, wherein the constitutive promoter is selected from UBI, LLDAV, EVCV, DMMV, BSV(AY) PRO, CYMV PRO FL, UBIZM PRO, SI-UB3 PRO, SB-UBI PRO (ALT1), USB1ZM PRO, ZM-GOS2 PRO, ZM-H1B PRO (1.2 KB), IN2-2, NOS, the −135 version of 35S, or ZM-ADF PRO (ALT2);
the inducible promoter is selected from AXIG1, DR5, XVE, GLB1, OLE, LTP2, HSP17.7, HSP26, HSP18A, AT-HSP811, AT-HSP811L, GM-HSP173B or promoters activated by tetracycline, ethamethsulfuron or chlorsulfuron; and
the developmentally regulated promoter is selected from PLTP, PLTP1, PLTP2, PLTP3, SDR, LGL, LEA-14A, or LEA-D34.

### Claim 39 (depends on 21)

The method of claim 21, further comprising excising or segregating away the marker gene cassette from the transgenic plant expressing the trait gene cassette.

### Claim 40 (depends on 24)

The method of claim 24, further comprising excising or segregating away the marker gene cassette and the morphogenic gene cassette from the transgenic plant expressing the trait gene cassette.

### Claim 41 (depends on 33)

The method of claim 33, further comprising excising or segregating away the marker gene cassette, the morphogenic gene cassette, and the site-specific recombinase cassette from the transgenic plant expressing the trait gene cassette.

### Claim 42 (depends on 21)

The method of claim 21, wherein the plant cell is a monocot or a dicot.

### Claim 43 (depends on 21)

A seed from the transgenic plant of claim 21.

### Claim 44 (depends on 21)

A seed of the transgenic plant produced by the method of claim 21, wherein the seed comprises the trait gene cassette and not the marker gene cassette.

### Claim 45 (depends on 24)

A seed of the transgenic plant produced by the method of claim 24, wherein the seed comprises the trait gene cassette and not the marker gene cassette or the morphogenic gene cassette.

### Claim 46 (depends on 33)

A seed of the transgenic plant produced by the method of claim 33, wherein the seed comprises the trait gene cassette and not the marker gene cassette or the morphogenic gene cassette or the site-specific recombinase cassette.

### Claim 47 (depends on 21)

The method of any one of claim 21, wherein the recombinant expression cassette resides in a disarmed Agrobacteria, an Ochrobactrum bacteria or a Rhizobiaceae bacteria.

### Claim 48 (depends on 47)

The method of claim 47, wherein the disarmed Agrobacteria is selected from the group of AGL-1, EHA105, GV3101, LBA4404, and LBA4404 THY-.

### Claim 49 (depends on 47)

The method of claim 47, wherein the Ochrobactrum bacteria is selected from Table 2.

### Claim 50 (depends on 47)

The method of claim 47, wherein the Rhizobiaceae bacteria is selected from Table 3.

### Claim 51 (depends on 24)

The method of claim 24, wherein the recombinant expression cassette resides in a disarmed Agrobacteria, an Ochrobactrum bacteria or a Rhizobiaceae bacteria.

### Claim 52

The method of 33, wherein the recombinant expression cassette resides in a disarmed Agrobacteria, an Ochrobactrum bacteria or a Rhizobiaceae bacteria.
